Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for premenstrual syndrome in women
IRCT20150825023760N9Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in premenstrual syndrome (PMS) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Menstrual distress. Started Jan 2025; status: completed.
02
Drugs
ketamine
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on IRCT20150825023760N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150825023760N9.